Associate Professor Michal Mazurek

Associate Professor Michal Mazurek

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

Member of:

- Practicing electrophysiologist (Silesian Centre for Heart Diseases, Zabrze, Poland, http://www.sccs.pl/en/) - EHRA Young EP Ambassador for Poland - Secretary of the Polish Heart Rhythm Society - Past Chairperson of the Katowice Division of Polish Cardiac Society - UK Foundation Programme graduate - University of Cambridge - Fellowship on atrial fibrillation at the University of Birmingham Main research interest: 1. Conduction system pacing (CSP) 2. Implantable devices (pacemakers, in particular CSP, ICDs, CRT, LOT-CRT) 3. Heart failure 4. Atrial fibrillation, atrial and ventricular arrhythmias 5. Ablation (both supra- and ventricular arrhythmias) Languages: 1. Polish 2. English 3. German Hobby: 1. Football 2. Bike

Presentations

Baseline creatinine level and long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy

Event: EHRA 2023

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: ePoster session 39

Access

Long-term outcome and mortality predictors in patients with extremely enlarged left ventricle end-diastolic diameter undergoing cardiac resynchronization therapy

Event: ESC Congress 2022

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Chronic heart failure - ICD, device and cardiac resynchronisation therapy

Access

10-year survival in patients undergoing cardiac resynchronization therapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Chronic heart failure e-posters

Access

10-year outcomes of triple-site versus standard cardiac resynchronization therapy randomized trial (TRUST CRT)

Event: ESC Congress 2020

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Device Therapy ePosters

Access

Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

Event: ESC Congress 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Outcomes in atrial fibrillation

Access

Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

Event: ESC Congress 2016

Topic: Primary care

Session: Best Posters in in transforming understanding of the elderly with cardiovascuclar disease

Access

Associate Professor Michal Mazurek

Biography

Contributor content

Baseline creatinine level and long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy

Long-term outcome and mortality predictors in patients with extremely enlarged left ventricle end-diastolic diameter undergoing cardiac resynchronization therapy

10-year survival in patients undergoing cardiac resynchronization therapy

10-year outcomes of triple-site versus standard cardiac resynchronization therapy randomized trial (TRUST CRT)

Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

ESC 365 is supported by